What about the trip? The relationship between ketamine’s acute and antidepressant effect

Abstract Ketamine has been established as a rapid and potent antidepressant. However, despite its groundbreaking efficacy, it has several limitations, including the transient nature of its antidepressant effects following a single infusion, as well as the phenomenology of acute intoxication. This state is characterized by altered consciousness, manifesting as dissociative or psychotomimetic phenomena, along with cardiovascular changes, such as fluctuations in systolic and diastolic blood pressure. The presentation explores whether these phenomena should be regarded as mere side effects or if they might play a role in ketamine’s antidepressant mechanisms. Furthermore, it addresses the ongoing challenge of identifying clinical and phenomenological predictors of a better antidepressant response. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.85
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What about the trip? The relationship between ketamine’s acute and antidepressant effect

Veronika Andrashko
European Psychiatry
Treatment of Major Depression
article

What about the trip? The relationship between ketamine’s acute and antidepressant effect

Veronika Andrashko
article en

Abstract

Abstract Ketamine has been established as a rapid and potent antidepressant. However, despite its groundbreaking efficacy, it has several limitations, including the transient nature of its antidepressant effects following a single infusion, as well as the phenomenology of acute intoxication. This state is characterized by altered consciousness, manifesting as dissociative or psychotomimetic phenomena, along with cardiovascular changes, such as fluctuations in systolic and diastolic blood pressure. The presentation explores whether these phenomena should be regarded as mere side effects or if they might play a role in ketamine’s antidepressant mechanisms. Furthermore, it addresses the ongoing challenge of identifying clinical and phenomenological predictors of a better antidepressant response. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
Third Way (US)
Openalex Percentile: Top 72%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.